Point72 Hong Kong LTD Standard Biotools Inc. Transaction History

Point72 Hong Kong LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.8 - $3.96 $1,940 - $2,744	-693 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.63 - $6.13 $2,515 - $4,248	693 New	693 $3,000
Q1 2021 May 17, 2021	SELL	$3.94 - $7.09 $4,578 - $8,238	-1,162 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$5.45 - $8.65 $6,332 - $10,051	1,162 New	1,162 $7,000
Q3 2020 Nov 16, 2020	SELL	$4.34 - $11.43 $36,508 - $96,149	-8,412 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.85 - $5.29 $15,562 - $44,499	8,412 New	8,412 $34,000
Q4 2019 Feb 14, 2020	SELL	$2.3 - $5.12 $1,761 - $3,921	-766 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$4.63 - $12.15 $3,074 - $8,067	664 Added 650.98%	766 $4,000
Q2 2019 Aug 14, 2019	BUY	$11.49 - $14.17 $1,171 - $1,445	102 New	102 $1,000
Q1 2019 May 15, 2019	SELL	$8.47 - $14.36 $16,025 - $27,169	-1,892 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$7.18 - $8.83 $13,584 - $16,706	1,892 New	1,892 $16,000

142

279M

27.2K

34.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $144M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.